8β-Hydroxy-exo-THC is a cannabinoid ether analogue with a weaker affinity for receptor sites, with an IC50 of 1.2 μM.

6',7'-Epoxy cannabigerol is a phytocannabinoid metabolite.

5'-Hydroxy-9(S)-hexahydrocannabinol is structurally similar to known phytocannabinoids.

5'-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid metabolite.

5-Fluoro THJ is a derivative of THJ-018. THJ-018 is a synthetic cannabinoid.

3-CAF is a synthetic cannabinoid featuring a 3-carboxylate-indazole structure.

2-Fluoro QMPSB (QMDFPSB) is structurally similar to known synthetic cannabinoids.

11-Hydroxy-9(S)-hexahydrocannabinol is a phytocannabinoid metabolite.

11-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid metabolite.

10α-Hydroxy-Δ8-THC (10α-Hydroxy-Δ8-tetrahydrocannabinol) is a phytocannabinoid.

(±)-CBCP ((±)-Cannabichromephorol) is structurally similar to known phytocannabinoids.

(±)-Cannabichromeorcin is a cannabinoid.

(±)-Cannabichromebutolic acid is structurally similar to known phytocannabinoids.

(±)-9α-Hydroxy hexahydrocannabinol ((±)-9α-Hydroxy HHC) is structurally similar to known phytocannabinoids.

8'-Hydroxy cannabichromene is a phytocannabinoid metabolite.

(±)-6',7'-Epoxy cannabichromene is a phytocannabinoid metabolite.

(±)-6',7'-Dihydroxy cannabichromene is a phytocannabinoid metabolite.

(-)-7-Nor-7-carboxy cannabidiol is a phytocannabinoid metabolite. (-)-7-Nor-7-carboxy cannabidiol is a metabolite of Cannabidiol.

Δ9-THCH is structurally similar to known phytocannabinoids.

Pregnenolone-d4-1 (3β-Hydroxy-5-pregnen-20-one-d4-1) is the deuterium labeled Pregnenolone. Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone can protect the brain from cannabis intoxication. Pregnenolone is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels.

TM38837 is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist. TM38837 shows limited penetrance to the brain in order to minimize or prevent CNS adverse reactions, and preserves potential antiobesity effects. TM38837 reduces propensity for psychiatric side effects.

URB447 (URB-447) is a peripherally restricted CB(1) antagonist/CB(2) agonist with IC50 of 313 nM (rat CB1) and 41 nM (human CB2).

LEI-102 (LEI 102) is a potent, selective cannabinoid CB2 receptor agonist with binding pKi of 8.0, 1000-fold selectivity over CB1R.

JWH133 (JWH-133) is a potent and selective CB2 agonist with Ki of 3.4 nM, 200-fold selective over CB1 receptors, inhibits glioma growth in vivo.

JM-00266 is a novel non-brain penetrant cannabinoid receptor 1 (CB1R) inverse agonist.

AM6527 is a highly potent, selective cannabinoid CB1 receptor antagonist with binding Ki of 4.88 nM, 100-fold selective over CB2 receptors.

CB-25 is a ligand of CB1 cannabinoid receptors, acting as a partial agonist. CB-25 enhances Forskolin-induced cAMP formation in cancer cells but not hCB1-CHO cells.

Pirnabine is a cannabinoid receptor ligand. Pirnabine can be used for the research of glaucoma.

GW 833972A is a selective CB2 receptor agonist. GW 833972A inhibits induced nerve depolarization and citric acid-induced cough in animal models.

WIN 55212-2 (mesylate) is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki of 62.3 and 3.3 nM for human recombinant CB1 and CB2 receptors, respectively.